MY120650A - Method and composition for ameliorating the adverse effects of aging. - Google Patents

Method and composition for ameliorating the adverse effects of aging.

Info

Publication number
MY120650A
MY120650A MYPI9100865A MY120650A MY 120650 A MY120650 A MY 120650A MY PI9100865 A MYPI9100865 A MY PI9100865A MY 120650 A MY120650 A MY 120650A
Authority
MY
Malaysia
Prior art keywords
cells
aging
adverse effects
kinetin
methods
Prior art date
Application number
Inventor
Suresh I S Rattan
Original Assignee
Senetek Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senetek Plc filed Critical Senetek Plc
Priority to MYPI9100865 priority Critical patent/MY120650A/en
Publication of MY120650A publication Critical patent/MY120650A/en

Links

Abstract

6-(SUBSTITUTED AMINO) PURINE CYTOKININS, INCLUDING KINETIN, HAVE BEEN DISCOVERED TO AMELIORATE THE ADVERSE EFFECTS OF AGING ON MAMMALIAN CELLS, BY SLOWING OR REVERSING THE MORPHOLOGICAL CHANGES THAT NORMALLY ACCOMPANY AGING OF SUCH CELLS, WITHOUT SIGNIFICANTLY INCREASING THE GROWTH RATE OR TOTAL PROLIFERATIVE CAPACITY OF SUCH CELLS. THUS, METHODS ARE PROVIDED FOR COUNTERING THE ADVERSE EFFECTS OF AGING ON CELLS IN CULTURE AND IN VIVO WHICH COMPRISE ADMINISTERING TO SAID CELLS AN ADVERSE-AGE-EFFECT-AMELIORATIVE AMOUNT OF KINETIN OR ANOTHER 6-(SUBSTITUTED AMINO) PURINE CYTOKININ. COMPOSITIONS FOR CARRYING OUT THE METHODS ARE ALSO PROVIDED. AMONG THE PREFERRED APPLICATIONS OF THE INVENTION ARE THE PRESERVATION TO HUMAN SKIN OF KINETIN-CONTAINING LOTIONS, OINTMENTS OR CREAMS, THE HEALTH AND YOUTHFUL APPEARANCE OF SKIN.
MYPI9100865 1991-05-22 1991-05-22 Method and composition for ameliorating the adverse effects of aging. MY120650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9100865 MY120650A (en) 1991-05-22 1991-05-22 Method and composition for ameliorating the adverse effects of aging.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9100865 MY120650A (en) 1991-05-22 1991-05-22 Method and composition for ameliorating the adverse effects of aging.

Publications (1)

Publication Number Publication Date
MY120650A true MY120650A (en) 2005-11-30

Family

ID=47257120

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9100865 MY120650A (en) 1991-05-22 1991-05-22 Method and composition for ameliorating the adverse effects of aging.

Country Status (1)

Country Link
MY (1) MY120650A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853386A (en) * 1985-08-17 1989-08-01 Boehringer Mannheim Gmbh N6 -disubstituted purine derivatives, and pharmaceutical compositions containing them, useful for treating allergic diseases, bronchospastic and bronchoconstrictory conditions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853386A (en) * 1985-08-17 1989-08-01 Boehringer Mannheim Gmbh N6 -disubstituted purine derivatives, and pharmaceutical compositions containing them, useful for treating allergic diseases, bronchospastic and bronchoconstrictory conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE MERCK INDEX, 9TH ED. PUB. 1976 PAGE 696, PARAGRAPH 5159. *

Similar Documents

Publication Publication Date Title
Guo et al. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture
Werner et al. Human macrophages degrade tryptophan upon induction by interferon-gamma
IL110091A0 (en) Imidazo [4,5-c] pyridin-4-amines and pharmaceutical compositions containing them
MX9709859A (en) C-4' modified adenosine kinase inhibitors.
AP1411A (en) Pyrrolo[2,3d] pyrimidine compositions and their use.
ES2102196T3 (en) PERIPHERIALIZATION OF HEMATOPOYETIC PLURIPOTENTIAL CELLS.
EP1572961A4 (en) Actriib fusion polypeptides and uses therefor
PT1053256E (en) Antibodies to death receptor 4 (dr4) and uses thereof
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
MY103388A (en) Azithromycin and derivatives as antiprotozoal agents
NZ223549A (en) Macromolecular antitumour compositions containing platinum
ATE79720T1 (en) METHODS OF PRESERVING TRANSPLANTABLE EPITHELIAL TISSUES CULTURED IN VITRO.
FI904604A0 (en) PYRIMIDIN-4,6-DICARBOXYLSYRAAMIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DERAS ANVAENDNING SAMT PAO DESSA FOERENINGAR BASERADE CEEKEMEDEL.
CA2108369A1 (en) Method and composition for ameliorating the adverse effects of aging
UA29466C2 (en) Pharmaceutical composition with antitumour activity
EP0610286A4 (en) Recombinant immunotoxins.
CA2151826A1 (en) Pharmaceutical compositions for prevention and treatment of cancerous diseases and process for their preparation
MY120650A (en) Method and composition for ameliorating the adverse effects of aging.
ES8301244A1 (en) Sisomicin derivatives, process for their preparation and their use as pharmaceutical compositions.
GR3026154T3 (en) Vitamin D3-analogs.
AU5312586A (en) Composition and method for treatment of tumors with UDPG
CA2107896A1 (en) Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
SI1140149T1 (en) Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
ES2018726A6 (en) Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof.
IL97801A0 (en) Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same